We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Cordis Corporation Acquires Ensure Medical

By HospiMedica staff writers
Posted on 07 Aug 2006
Print article
In a move to expand its portfolio of vascular wound-closure devices, Cordis Corporation (Miami Lakes, FL, USA) has acquired Ensure Medical (Sunnyvale, CA, USA), a privately held company that develops devices for post-catheterization closure of the femoral artery. Financial details were not disclosed.

The lead investigational technology of Ensure Medical is a femoral artery closure device (ACD) that uses a synthetic bioabsorbable polymer to stop bleeding and close the site of the arterial puncture. ACDs are designed to enable rapid closure time and reduce bed-stay when compared to conventional manual compression methods for wound-access site closure. Nearly eight million patients undergo cardiac catheterization procedures annually in the United States alone.

"Bioabsorbable wound closure has had a significant impact on patients during post-catheterization recovery. We have seen evidence to indicate that patients may experience less pain and can return to self-sufficiency much sooner,” said Peter Fitzgerald, M.D. Ph.D., professor of medicine, Stanford University Hospital (CA, USA), and one of the founders of Ensure Medical. "Ensure is excited about working with Cordis to accelerate this new ACD into the market and make a difference for healthcare providers and the patients they treat.”

"The addition of Ensure Medical enriches Cordis' ever-expanding portfolio of cardiac and vascular devices to offer healthcare professionals a broader range of innovative technologies to effectively treat the continuum of cardiovascular disease,” said Rick Anderson, company group chairman, Johnson & Johnson, and worldwide chairman of the Cordis franchise. Cordis is a division of Johnson & Johnson.

Cordis expects the investigational bioabsorbable ACD to enter into clinical trials in early 2007 in order to secure approval for marketing from the U.S. Food and Drug Administration (FDA) and regulatory authorities elsewhere around the world.



Related Links:
Cordis Corporation
Johnson & Johnson
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Diagnostic Ultrasound System
MS1700C
New
Medical-Grade POC Terminal
POC-821

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.